Brief: Cadrenal Therapeutics Receives Legal Opinion From Blank Rome LLP On Validity Of Share Offering
18/11/2025 21:46
Nov 19 (Reuters) - Cadrenal Therapeutics Inc CVKD.O: CADRENAL THERAPEUTICS: BLANK ROME LLP ISSUED LEGAL OPINION ON VALIDITY OF $3.4 MILLION SHARES THAT MAY BE OFFERED & SOLD PURSUANT TO ATM AGREEMENT - SEC FILING Source text: [ID:] Further company coverage: CVKD.O ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cadrenal Therapeutics
See all newsCadrenal Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Cadrenal Therapeutics Q2 net loss narrows as operating expenses fall
Cadrenal Therapeutics Inc expected to post a loss of $1.42 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Marvell Technology